Mithra Pharmaceuticals SA

EBR:MITRA.BR

0.216 (EUR) • At close July 23, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) EUR.

2023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q4
Assets:
Current Assets:
Cash & Cash Equivalents 8.9823.71428.28529.29932.87255.83138.67562.57649.7277.466118.94985.75736.1944.7452.155.8977.79426.5122.113
Short Term Investments 0000000.0140.0160.0460000043.6608900
Cash and Short Term Investments 8.9823.71428.28529.29932.87255.83138.68962.59249.76677.466118.94985.75736.1944.74545.7565.89796.79426.5122.113
Net Receivables 36.09219.56462.59624.30320.25324.87859.95762.62725.5299.6975.19417.81525.42911.8653.5098.7325.9516.1394.805
Inventory 48.28949.44750.31248.21243.85239.42235.3824.12616.22714.1110.9456.6754.1413.1134.173.5622.7973.3821.763
Other Current Assets 0.0470.2014.67-0.0012.4121.6544.4490.1413.0460.0018.2740.4348.45204.446-03.5472.8090.001
Total Current Assets 93.40892.926145.863101.81399.389121.784238.475149.48691.522101.274143.362110.68174.21259.72357.87578.191109.08938.8428.682
Non-Current Assets:
Property, Plant & Equipment, Net 51.488102.31106.251107.141107.676104.48899.49396.36894.03790.8384.39663.89159.51953.98216.9618.0983.5732.4592.44
Goodwill 5.2335.2335.2335.2335.2335.2335.2335.2335.2335.2335.2335.2335.2335.2335.2335.2338.0163.8133.814
Intangible Assets 108.713141.77140.138120.113110.187106.68594.23897.16692.72390.73578.80280.94378.8178.94379.1380.11978.23441.68441.649
Goodwill and Intangible Assets 113.946147.003145.371125.346115.42111.91899.471102.39997.95695.96884.03586.17684.04384.17684.36385.35286.2545.49745.463
Long Term Investments 16.19411.58524.32330.44331.98736.10432.69519.96680.06729.418141.386118.981120.8440.0890.1650.1760.1983.1543.619
Tax Assets 1.28916.00916.35464.52963.45659.31750.90545.09234.43149.53227.04531.08622.71815.73812.1938.5335.3452.4150.563
Other Non-Current Assets 10.2214.9114.2523.2283.992.9850.9468.152-0.373.372-27.045-31.086-22.718-15.738-12.193-8.533-5.345-2.4150.252
Total Non-Current Assets 193.138281.818296.551330.687322.529314.812283.51271.977306.121269.12168.431150.067143.562138.247101.48993.62690.02151.1152.337
Total Assets 286.546374.744442.414432.5421.918436.596521.985421.463397.643370.394359.728295.471244.712214.849172.696181.49205.58792.62961.019
Liabilities & Equity:
Current Liabilities:
Account Payables 59.07244.71131.71627.57623.33119.3127.27216.60727.11213.69313.07110.03216.14117.8179.31222.7654.6137.7485.393
Short Term Debt 26.70326.99752.41154.553.12817.41118.79219.69920.68718.25812.57816.25316.2376.7996.9554.1417.8543.1323.214
Tax Payables 0000000.03600.0930.3860.370.124-0.0110.0910.0980.050.6050.0070.31
Deferred Revenue 2.5071.4991.4171.7451.6171.6641.259-19.699-28.3510.386-12.578-16.253-16.237-6.799-6.955-4.14-17.854-3.130.31
Other Current Liabilities 15.69915.86444.88743.58117.7178.75223.424000.38410.467.12619.8396.77311.4380.0512.0730.007-0.001
Total Current Liabilities 103.98189.071130.431127.40295.79347.13770.74736.30647.79932.33536.10933.41152.21731.38927.70526.95534.5410.88528.916
Non-Current Liabilities:
Long Term Debt 147.53146.415137.762125.578125.237124.657124.508138.454132.008218.371118.23697.77869.18944.34948.24242.62337.69627.50926.579
Deferred Revenue Non-Current 17.94718.8928.12711.57212.76913.47618.9014.0564.0554.0170.4468.9590.4954.5428.2558.5178.5136.6980
Deferred Tax Liabilities Non-Current 1.0813.5744.425.2686.095.7034.3644.1454.1483.4032.2022.9492.0995.633.4693.4945.69220.8110
Other Non-Current Liabilities 119.264125.521127.987126.554148.189147.543145.72850.97846.33548.335-2.648-11.908-2.594-10.172-11.724-12.011-14.205-6.6980
Total Non-Current Liabilities 285.822294.402278.296268.972292.285291.379293.501197.633186.546274.126118.23697.77869.18944.34948.24242.62337.69627.50926.579
Total Liabilities 389.803383.473408.727396.374388.078338.516364.248233.939234.345306.461208.835167.634157.83114.86579.68173.33878.19338.45955.495
Equity:
Preferred Stock 0000000000000000000
Common Stock 50.59442.89141.22837.03132.2532.0231.27130.45828.01826.96126.92526.92525.03624.81722.61322.61322.61317.9513.107
Retained Earnings -589.294-464.763-396.254-367.881-336.634-274.652-219.759-161.668-127.673-190.854-101.109-123.192-88.744-72.525-53.733-38.241-18.645-14.847-8.154
Accumulated Other Comprehensive Income/Loss 10.586-0.021-19.934-18.083-2.5455.42613.69-1.6723.4246.10600000000-1.036
Other Total Stockholders Equity 424.859413.163408.647385.058340.769335.286332.535320.407259.529221.72225.077224.104150.59147.692124.135123.78123.42651.06611.607
Total Shareholders Equity -103.255-8.7333.68736.12533.8498.08157.737187.525163.29863.933150.893127.83786.88299.98493.015108.152127.39454.175.524
Total Equity -103.255-8.7333.68736.12533.8498.08157.737187.525163.29863.933150.893127.83786.88299.98493.015108.152127.39454.175.524
Total Liabilities & Shareholders Equity 286.546374.743442.414432.499421.918436.596521.985421.464397.643370.394355.684295.471244.712214.849172.696181.49205.58792.62961.019